Tekla Capital Management as of Dec. 31, 2015
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 134 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 8.6 | $236M | 2.3M | 101.19 | |
| Celgene Corporation | 7.4 | $205M | 1.7M | 119.76 | |
| Biogen Idec (BIIB) | 5.0 | $138M | 451k | 306.35 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.7 | $130M | 1.0M | 125.83 | |
| Allergan | 4.6 | $128M | 410k | 312.50 | |
| Alexion Pharmaceuticals | 4.4 | $122M | 637k | 190.75 | |
| Johnson & Johnson (JNJ) | 3.5 | $97M | 941k | 102.72 | |
| Incyte Corporation (INCY) | 3.5 | $96M | 881k | 108.45 | |
| Teva Pharmaceutical Industries (TEVA) | 3.2 | $88M | 1.3M | 65.64 | |
| Regeneron Pharmaceuticals (REGN) | 3.0 | $84M | 154k | 542.87 | |
| Illumina (ILMN) | 3.0 | $83M | 434k | 191.95 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $63M | 596k | 104.76 | |
| Pfizer (PFE) | 2.1 | $58M | 1.8M | 32.28 | |
| Amgen (AMGN) | 1.9 | $52M | 322k | 162.33 | |
| UnitedHealth (UNH) | 1.8 | $48M | 409k | 117.64 | |
| Alkermes (ALKS) | 1.5 | $41M | 510k | 79.38 | |
| Merck & Co (MRK) | 1.3 | $36M | 681k | 52.82 | |
| Shire | 1.3 | $35M | 172k | 205.00 | |
| Medivation | 1.2 | $32M | 667k | 48.34 | |
| Agilent Technologies Inc C ommon (A) | 1.1 | $31M | 729k | 41.81 | |
| Hca Holdings (HCA) | 1.1 | $30M | 449k | 67.63 | |
| Mylan Nv | 1.0 | $29M | 531k | 54.07 | |
| Humana (HUM) | 0.8 | $23M | 129k | 178.51 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $23M | 638k | 35.65 | |
| Ventas (VTR) | 0.8 | $21M | 369k | 56.43 | |
| Molina Healthcare (MOH) | 0.8 | $21M | 348k | 60.13 | |
| Physicians Realty Trust | 0.8 | $21M | 1.2M | 16.86 | |
| Puma Biotechnology (PBYI) | 0.7 | $20M | 260k | 78.40 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.7 | $20M | 58k | 338.32 | |
| Medical Properties Trust (MPW) | 0.7 | $18M | 1.6M | 11.51 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $18M | 312k | 56.57 | |
| Endo International (ENDPQ) | 0.6 | $18M | 286k | 61.22 | |
| Novo Nordisk A/S (NVO) | 0.6 | $17M | 295k | 58.08 | |
| McKesson Corporation (MCK) | 0.6 | $16M | 83k | 197.23 | |
| Horizon Pharma | 0.6 | $16M | 750k | 21.67 | |
| St. Jude Medical | 0.6 | $16M | 256k | 61.77 | |
| Medicines Company | 0.5 | $15M | 402k | 37.34 | |
| Impax Laboratories | 0.5 | $15M | 345k | 42.76 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $15M | 93k | 156.61 | |
| Omega Healthcare Investors (OHI) | 0.5 | $15M | 413k | 34.98 | |
| Paratek Pharmaceuticals | 0.5 | $15M | 763k | 18.97 | |
| Bristol Myers Squibb (BMY) | 0.5 | $14M | 203k | 68.79 | |
| Corsicanto Ltd conv bnd | 0.5 | $13M | 15M | 0.91 | |
| Sanofi-Aventis SA (SNY) | 0.5 | $13M | 305k | 42.65 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $13M | 138k | 94.14 | |
| Anacor Pharmaceuticals In | 0.5 | $12M | 110k | 112.97 | |
| Baxalta Incorporated | 0.5 | $13M | 320k | 39.03 | |
| Baxter International (BAX) | 0.4 | $12M | 320k | 38.15 | |
| Thermo Fisher Scientific (TMO) | 0.4 | $12M | 86k | 141.85 | |
| Cepheid | 0.4 | $12M | 334k | 36.53 | |
| Welltower Inc 6.50% pfd prepet | 0.4 | $12M | 200k | 60.91 | |
| GlaxoSmithKline | 0.4 | $12M | 285k | 40.35 | |
| Stryker Corporation (SYK) | 0.4 | $12M | 124k | 92.94 | |
| Alere | 0.4 | $12M | 298k | 39.09 | |
| Ardelyx (ARDX) | 0.4 | $12M | 639k | 18.12 | |
| Zimmer Holdings (ZBH) | 0.4 | $11M | 102k | 102.59 | |
| LTC Properties (LTC) | 0.4 | $10M | 237k | 43.14 | |
| Intra Cellular Therapies (ITCI) | 0.4 | $10M | 188k | 53.79 | |
| Senior Housing Properties Trust | 0.4 | $10M | 671k | 14.84 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $9.9M | 88k | 112.18 | |
| IDEXX Laboratories (IDXX) | 0.3 | $9.7M | 132k | 72.92 | |
| Medtronic (MDT) | 0.3 | $9.6M | 124k | 76.92 | |
| Natera (NTRA) | 0.3 | $9.5M | 882k | 10.80 | |
| Sabra Health Care REIT (SBRA) | 0.3 | $9.2M | 456k | 20.23 | |
| Icon (ICLR) | 0.3 | $8.9M | 115k | 77.70 | |
| Cepheid conv | 0.3 | $8.9M | 10M | 0.89 | |
| Pieris Pharmaceuticals (PIRS) | 0.3 | $8.8M | 3.8M | 2.29 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.3 | $8.6M | 13M | 0.66 | |
| Universal Health Services (UHS) | 0.3 | $8.4M | 70k | 119.49 | |
| Novartis (NVS) | 0.3 | $8.0M | 93k | 86.04 | |
| Community Health Systems (CYH) | 0.3 | $8.1M | 305k | 26.53 | |
| Centene Corporation (CNC) | 0.3 | $7.9M | 120k | 65.81 | |
| Juno Therapeutics | 0.3 | $8.0M | 182k | 43.97 | |
| Eli Lilly & Co. (LLY) | 0.3 | $7.2M | 86k | 84.26 | |
| WellCare Health Plans | 0.2 | $6.9M | 89k | 78.20 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $6.8M | 328k | 20.87 | |
| Merrimack Pharmaceuticals In | 0.2 | $6.7M | 854k | 7.90 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $6.6M | 500k | 13.25 | |
| Dynavax Technologies (DVAX) | 0.2 | $6.6M | 275k | 24.16 | |
| Retrophin | 0.2 | $6.4M | 330k | 19.29 | |
| Cellectis S A (CLLS) | 0.2 | $6.4M | 207k | 31.03 | |
| Auris Med Hldg | 0.2 | $6.2M | 1.3M | 4.89 | |
| Exelixis (EXEL) | 0.2 | $5.8M | 1.0M | 5.64 | |
| Flamel Technologies | 0.2 | $5.8M | 474k | 12.21 | |
| Accelr8 Technology | 0.2 | $5.7M | 265k | 21.49 | |
| Heron Therapeutics (HRTX) | 0.2 | $5.8M | 219k | 26.70 | |
| Sage Therapeutics (SAGE) | 0.2 | $5.7M | 98k | 58.30 | |
| Akorn | 0.2 | $5.4M | 145k | 37.31 | |
| Endologix | 0.2 | $5.5M | 551k | 9.90 | |
| Perrigo Company (PRGO) | 0.2 | $5.4M | 37k | 144.69 | |
| Healthcare Realty Trust Incorporated | 0.2 | $5.3M | 187k | 28.32 | |
| Foamix Pharmaceuticals | 0.2 | $5.3M | 652k | 8.11 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.2 | $5.4M | 2.0M | 2.68 | |
| Allergan Plc pfd conv ser a | 0.2 | $5.2M | 5.0k | 1030.20 | |
| Tenet Healthcare Corporation (THC) | 0.2 | $5.0M | 165k | 30.30 | |
| Sagent Pharmaceuticals | 0.2 | $4.6M | 287k | 15.91 | |
| Mallinckrodt Pub | 0.2 | $4.6M | 62k | 74.64 | |
| Inotek Pharmaceuticals | 0.2 | $4.8M | 425k | 11.33 | |
| Arca Biopharma | 0.1 | $3.8M | 811k | 4.65 | |
| DepoMed | 0.1 | $3.6M | 200k | 18.13 | |
| Halozyme Therapeutics (HALO) | 0.1 | $3.5M | 200k | 17.33 | |
| Alliqua | 0.1 | $3.5M | 1.7M | 2.14 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $3.6M | 297k | 12.06 | |
| Novavax | 0.1 | $3.0M | 358k | 8.39 | |
| Bluebird Bio (BLUE) | 0.1 | $3.2M | 49k | 64.22 | |
| Uniqure Nv (QURE) | 0.1 | $2.9M | 176k | 16.54 | |
| Flex Pharma | 0.1 | $2.9M | 233k | 12.45 | |
| Allscripts Healthcare Solutions (MDRX) | 0.1 | $2.7M | 174k | 15.38 | |
| Insmed (INSM) | 0.1 | $2.8M | 157k | 18.15 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.7M | 83k | 32.40 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $2.6M | 198k | 13.31 | |
| Cynapsus Therapeutics | 0.1 | $2.8M | 180k | 15.44 | |
| Kite Pharma | 0.1 | $2.5M | 41k | 61.61 | |
| Forward Pharma A/s | 0.1 | $2.6M | 137k | 19.00 | |
| Dbv Technologies S A (DBVT) | 0.1 | $2.4M | 66k | 36.31 | |
| Care Cap Properties | 0.1 | $2.6M | 84k | 30.58 | |
| Momenta Pharmaceuticals | 0.1 | $2.3M | 154k | 14.84 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $2.1M | 30k | 69.43 | |
| Esperion Therapeutics (ESPR) | 0.1 | $2.3M | 103k | 22.26 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $2.2M | 1.5M | 1.48 | |
| Affimed Therapeutics B V | 0.1 | $2.1M | 294k | 7.12 | |
| Tetraphase Pharmaceuticals | 0.1 | $1.9M | 192k | 10.03 | |
| Celldex Therapeutics | 0.1 | $1.7M | 106k | 15.68 | |
| Nevro (NVRO) | 0.1 | $1.7M | 25k | 67.52 | |
| Galapagos Nv- (GLPG) | 0.1 | $1.3M | 20k | 62.90 | |
| Bellicum Pharma | 0.0 | $1.2M | 60k | 20.27 | |
| GenMark Diagnostics | 0.0 | $724k | 93k | 7.76 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $901k | 53k | 17.16 | |
| Chimerix (CMRX) | 0.0 | $428k | 48k | 8.95 | |
| Xencor (XNCR) | 0.0 | $292k | 20k | 14.60 | |
| Abbvie (ABBV) | 0.0 | $9.0k | 156.00 | 57.69 | |
| Zafgen | 0.0 | $84k | 13k | 6.31 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $107k | 7.4k | 14.38 | |
| Gilead Sciences | 0.0 | $27k | 278.00 | 97.12 |
